Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-06

Clinical Trial Update: Clinical Study of Hydroxytyrosol (HT) in Mitochondrial Diseases [NA]

View source ↗

Summary

A clinical study evaluating hydroxytyrosol for mitochondrial diseases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxytyrosol (hydroxytyrosol)

Snippet

Sponsor: Hong Kong Children's Hospital | Conditions: Mitochondrial Diseases | NA | Status: COMPLETED